BG Growth Series – Avantium
BG Growth Series – Avantium
Welcome to the “BG Growth Series“, where entrepreneurs share their inspiring stories, insights, and tips to navigate the path of innovation and growth.
In this episode, we feature Avantium, a pioneering commercial-stage company at the forefront of renewable and circular polymer materials. Avantium’s groundbreaking work in developing FDCA – the key building block for the 100% plant-based, recyclable, and degradable plastic PEF – is setting a new standard in sustainable alternatives to fossil-based plastics.
We had the opportunity to sit down with Avantium’s CEO, Tom van Aken, to explore their journey and ambitious vision for the future. With the world’s first commercial FDCA flagship plant now completed and paving the way for the commercialisation of PEF, Avantium has reached a critical milestone.
In its latest phase of growth, Avantium partnered with Bryan, Garnier & Co, who acted as Sole Financial Advisor and Joint Global Coordinator in a EUR 70 million Rights Offering and Institutional Upsize ABB. This capital raise has financed the completion of the FDCA flagship plant and will accelerate the commercialisation of Avantium’s revolutionary technologies. It will also strengthens Avantium’s position, showcasing its long-term financial viability to stakeholders and prospective licensees.
From pioneering YXY® Technology to scaling PEF production, Avantium’s journey reflects an unwavering commitment to sustainability and innovation. Their partnership with Bryan, Garnier & Co represents a significant step in the company’s growth, positioning Avantium to drive transformative change in the global materials industry.
Watch this episode of the BG Growth Series to learn more about Avantium’s vision and their mission to redefine the future of sustainable plastics.
Get in touch
Whether you’re at the outset seeking funding, or an established firm searching for strategic options, our team will provide you with tailored advice to help you reach your goals.
All related deals:
Our transactions
Bryan, Garnier & Co offers a complete range of investment banking services, from growth financing to mergers and acquisitions.
About Bryan, Garnier & Co
Bryan, Garnier & Co is a European growth investment bank that helps healthcare and technology companies become global champions. By combining extensive sector expertise with an entrepreneurial mindset, Bryan Garnier provides companies and their investors with independent growth strategic advice, and privileged access to buyers and capital in Europe, the US and Asia.
As a full-service investment bank, the firm offering includes private and public growth financing solutions, mergers and acquisitions (M&A) advisory, research insights, and institutional sales & execution. Founded in 1996, Bryan Garnier & Co is an independent partnership with around 200 employees located in major financial centres in Europe and the US.